Interestingly, SNORD46 mutant mice led to improved glucose tolerance, decreased body weight, reduced liver steatosis and fatty acid accumulation, and decreased lipid accumulation in the liver, demonstrating that modifying SNORD46 may yield anticancer properties and anti-obesity properties [192]. Here, SNORD46 is linked to steatosis.